Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:

Knight Therapeutics Inc (GUD.TO)

Knight Therapeutics Inc (GUD.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Stocks in play: Knight Therapeutics Inc. Baystreet - Thu Nov 7, 9:17AM CST

Today reported financial results for its third quarter ended September 30, 2024. The company delivered ...

GUD.TO : 5.15 (-10.28%)
Knight Therapeutics Reports Third Quarter 2024 GlobeNewswire - Thu Nov 7, 6:30AM CST

GUD.TO : 5.15 (-10.28%)
Notice of Knight Therapeutics' Third Quarter 2024 Results Conference Call GlobeNewswire - Thu Oct 31, 6:30AM CDT

GUD.TO : 5.15 (-10.28%)
Knight Therapeutics Announces Approval of Minjuvi® (tafasitamab) in Mexico GlobeNewswire - Tue Oct 15, 7:30AM CDT

GUD.TO : 5.15 (-10.28%)
INCY : 82.34 (+1.72%)
Stocks in play: Knight Therapeutics Inc. Baystreet - Thu Mar 14, 8:40AM CDT

Will release its fourth-quarter and year-end 2023 financial results on Thursday, March 21, prior to ...

GUD.TO : 5.15 (-10.28%)
Stocks in play: Knight Therapeutics Inc., Baystreet - Thu Feb 29, 8:55AM CST

Announced today the launch of Minjuvi® (tafasitamab) by its Brazilian affiliate, United Medical Ltda. ...

GUD.TO : 5.15 (-10.28%)
Stocks in play: Knight Therapeutics Inc. Baystreet - Tue Dec 19, 2023

Has entered into an exclusive license agreement with Supernus Pharmaceuticals, Inc., a biopharmaceutical ...

GUD.TO : 5.15 (-10.28%)
Stocks in play: Knight Therapeutics Inc. Baystreet - Thu Nov 9, 2023

Reported financial results for its third quarter ended September 30, 2023. All currency amounts are ...

GUD.TO : 5.15 (-10.28%)
Stocks in play: Knight Therapeutics Inc. Baystreet - Mon Oct 16, 2023

Has received pricing approval for Minjuvi® (tafasitamab) from the Drugs Market Regulation Chamber (“CMED”). ...

GUD.TO : 5.15 (-10.28%)
Stocks in play: Knight Therapeutics Inc. Baystreet - Thu Aug 10, 2023

Reported financial results for its second quarter ended June 30, 2023. Revenues were $89.905 million, ...

GUD.TO : 5.15 (-10.28%)

Barchart Exclusives

3 Semiconductor Stocks to Buy on Cyclical Weakness Barchart - 30 minutes ago
These three semiconductor stocks with strong upside potential just dipped - making this cyclical weakness a prime buying opportunity for investors. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot